Daniel López L.
Senior Strategic Advisor – Global Health, Law, Policy & Regulation
Senior global health law and regulatory policy leader with more than 15 years of experience operating at the intersection of public health governance, pharmaceutical regulation, competition policy, and international health law. Recognized for transforming complex legal, regulatory, and policy challenges into actionable strategies that strengthen health systems, advance regulatory excellence, and expand equitable access to health technologies across Latin America and global markets.
Thera Contribution
As Senior Strategic Advisor at Thera Health Policy & Access, Daniel leads the firm’s global health governance and regulatory policy pillar, helping clients navigate highly complex legal, regulatory, and institutional environments that shape healthcare innovation, market access, and public health outcomes.
He plays a critical role in Thera’s Diagnosis → Design → Deliver phases, ensuring that policy and access strategies are grounded in sound regulatory analysis, international best practices, scientific and technical evidence, and a deep understanding of how governments, multilateral organizations, and healthcare stakeholders interact within evolving health systems.
His expertise enables Thera to bridge public and private sector perspectives, translating regulatory complexity into practical solutions that support sustainable healthcare innovation, institutional strengthening, the adoption of evidence-based public health policies, and improved equitable patient access to health technologies.
Executive Profile
Daniel is an internationally recognized expert in global health law, pharmaceutical regulation, and public health governance, with experience spanning international organizations, private practice, academia, government institutions, and civil society organizations. Throughout his career, he has advised governments, multilateral agencies, and healthcare stakeholders on the design, implementation, and evaluation of regulatory and policy frameworks that strengthen healthcare systems and advance public health objectives.
He brings a unique ability to connect legal, regulatory, political, and public health dimensions, ensuring that policy solutions are not only legally robust but also institutionally feasible and capable of delivering meaningful health outcomes.
A defining feature of his profile is his ability to operate effectively across multiple stakeholder environments, including:
- Governments and regulatory authorities
- International and multilateral organizations
- Pharmaceutical and life sciences companies
- Civil society and public health institutions
This multidisciplinary perspective allows him to bridge the worlds of regulation, governance, and healthcare innovation, helping organizations anticipate policy developments, manage regulatory risk, and navigate increasingly complex health ecosystems.
Areas of Strategic Impact
Global Health Governance & Regulatory Policy
Advises governments, international organizations, and healthcare stakeholders on the development of regulatory and policy frameworks that strengthen public health governance, transparency, and institutional effectiveness
Pharmaceutical Regulation & Market Access
Provides strategic guidance on regulatory systems, health product governance, pharmaceutical markets, and policy environments affecting innovation, competition, and patient access to medicines and health technologies.
International Health Law & Public Policy
Applies extensive expertise in international health law and multilateral frameworks to help organizations navigate evolving legal obligations, public health priorities, and global regulatory trends.
Multi-Stakeholder Engagement & Coalition Building
Facilitates collaboration among governments, international organizations, industry stakeholders, and civil society partners to support consensus-building, policy development, and effective implementation of health initiatives.
Regulatory Systems Strengthening & Capacity Building
Designs and delivers technical assistance programs, policy analyses, and institutional strengthening initiatives aimed at improving regulatory effectiveness, governance capacity, and evidence-based decision-making.
Professional Background
Daniel has held leadership and advisory roles across some of the most influential institutions involved in healthcare regulation, public health policy, and pharmaceutical governance.
Most recently, he served as Senior Legal Advisor at the Campaign for Tobacco-Free Kids, where he advised governments and international partners across Latin America, the Caribbean, Africa, and Eurasia on regulatory frameworks, public health governance, and the regulation of hazardous and addictive products. He represented the organization in international policy forums and supported the design and implementation of legislative and regulatory initiatives.
Previously, Daniel worked with the Pan American Health Organization (PAHO) as both an International Consultant and Legal Intern, supporting regional regulatory and public health policy initiatives throughout the Americas. His work included legal analysis, policy development, technical assistance, and capacity-building programs for governments and public health stakeholders.
Before relocating to Washington, D.C., he was Partner and Head of the Regulatory Litigation, Antitrust, and Life Sciences Practice at Albagli Zaliasnik, where he advised multinational pharmaceutical and healthcare companies on regulatory strategy, biosimilars, market access, competition law, and pharmaceutical policy. His clients included leading global healthcare organizations operating in highly regulated markets.
His professional experience is further complemented by research and policy work at the U.S. Federal Trade Commission and Georgetown University’s O’Neill Institute for National and Global Health Law, where he conducted comparative analyses on competition policy, healthcare markets, consumer protection, and global health governance.
Academic & Professional Credentials
- Master of Laws (LL.M.) in Global Health Law – Georgetown University Law Center (United States)
- Law Degree (Licenciatura en Derecho) – University of Chile Law School
- Member in Good Standing, Chilean Bar Association
- Litigation Star in Antitrust, Commercial Litigation, and Dispute Resolution
- Next Generation Partner in Competition & Antitrust Law (Legal 500)
- Co-author of peer-reviewed research published in the Pan American Journal of Public Health on governance and conflicts of interest in tobacco control across the Americas.
